title: A longitudinal study of ventricular volume in early relapsing-remitting multiple sclerosis.
abstract: The specific aim of this study was to determine whether progressive brain atrophy could be detected within 18 months of establishing a diagnosis of relapsing-remitting multiple sclerosis (RRMS). Fifteen patients with clinically definite RRMS (mean disease duration from first symptom=6 months, mean EDSS=1.2) completed 6 - 14 monthly quantitative MRI sessions. The volume of the lateral ventricles was determined each month using a semi-automated thresholding technique from T1-weighted axial images. The number of new monthly gadolinium-enhancing (Gd+) lesions and EDSS scores were also recorded. Lateral ventricular volumes increased significantly during this study. When individual data were examined, statistically significant changes were observed in six of 15 patients. Monthly change in ventricular volume was related to baseline EDSS and total number of new Gd(+) lesions. These observations indicate brain atrophy, a putative imaging marker of diffuse demyelination and axonal loss, can occur as early as 18 months after first symptoms of RRMS, and is related to the baseline level of disability and to the number of new Gd+ lesions. Multiple Sclerosis (2000) 6 332 - 337
authors.affiliation: Department of Radiology, University of California at San Francisco, AC-109, 1 Irving St, San Francisco, California, CA 94143, USA.
authors.forename: T L
authors.initials: TL
authors.lastname: Luks
authors.forename: D E
authors.initials: DE
authors.lastname: Goodkin
authors.forename: S J
authors.initials: SJ
authors.lastname: Nelson
authors.forename: S
authors.initials: S
authors.lastname: Majumdar
authors.forename: P
authors.initials: P
authors.lastname: Bacchetti
authors.forename: D
authors.initials: D
authors.lastname: Portnoy
authors.forename: R
authors.initials: R
authors.lastname: Sloan
mesh_terms: D000293:Adolescent; D000328:Adult; D001284:Atrophy; D002552:Cerebral Ventricles / Q000473:pathology*; D015331:Cohort Studies; D005682:Gadolinium; D006801:Humans; D008137:Longitudinal Studies; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000473:pathology*; D012044:Regression Analysis
chemical_list: D005682:Gadolinium